AlphAIAlphAI — Financial news for AI agents
tradingview.com$HNGE

Hinge Health 3Q 2026: Revenue $234.97M, EPS $0.66 — 10-Q Summary

Hinge Health reported 3Q 2026 revenue of $234.97M, up year-over-year, driven by member retention and growth. EPS was $0.66. Gross margin improved to 87% from 82%. Client base grew to 3,270. The company launched a Migraine Care Program and acquired Cylinder Health.

Original reporting
tradingview.com
Published Nov 9, 2026, 9:41 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 9:52 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Hinge Health 3Q 2026: Revenue $234.97M, EPS $0.66 — 10-Q Summary — source image
Source · tradingview.com
Decision brief

The 30-second read

$HNGEBullishMed
01

Why it matters

The earnings beat and acquisition suggest operational momentum, likely supporting short‑term price appreciation.

02

Market read

First disclosure of quarterly results provides fresh data for traders; modest upside potential for HNGE.

03

What to watch

Integration risk of Cylinder Health acquisition could offset margin gains.

Relevance 7/10Novelty 7/10Timing: after-hours release

Background

The article summarizes Hinge Health's Q3 2026 10‑Q filing, highlighting revenue, EPS, margin improvement, client growth, and a recent acquisition.

Company-level read

Ticker impact

$HNGEBullishHigh confidence
Context

Hinge Health reported Q3 2026 revenue of $234.97M and EPS of $0.66 in its 10‑Q filing, the first public disclosure of these numbers.

Expected impact

likely modest upside as investors price in stronger top‑line and margin improvement

Evidence & confidence

The fresh earnings data and acquisition signal operational progress, which typically supports a short‑term price lift.

Market effects

Sector

Positive signal for digital health and tele‑rehabilitation sector, may boost peer valuations.

Regional

U.S. health‑tech market sees incremental confidence.

Global

Limited to health‑tech niche, no broad macro effect.

Counterpoint

What could challenge this read

Revenue size is modest; growth may not be sustainable without further acquisitions.

Key entities

  • company
    Hinge Health, Inc.

    Digital health provider reporting Q3 2026 results.

  • company
    Cylinder Health

    Virtual‑first digestive healthcare company acquired by Hinge Health.

Read at source← All news

Related articles

$HNGEHighAI 8/10

Needham raises Hinge Health stock price target on client growth

Needham raised its price target for Hinge Health (NYSE:HNGE) to $135 from $115, citing strong client growth and quarterly performance. The company reported 28% year-over-year client growth, 50% revenue increase, and 154% stock return over six months. Q3 revenue was $235 million, up 52% year-over-year, with EPS of $0.66 beating estimates. Wells Fargo also raised its target to $132, noting strong margins and revenue growth.

investing.com
$HNGEHighAI 8/10

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.

finance.yahoo.com